Skip Main Navigation | Skip to Content

News of the Week Home

News of the Week

Olceseā€™s KynderMed selected as BioPitch semifinalist

KynderMed, a company co-founded by Florida State College of Medicine Biomedical Sciences Professor James Olcese, was one of 15 seed and early-stage life science companies selected as a semifinalist in BioFlorida’s startup competition, BioPitch.

All 15 semifinalists presented to a panel of investors at BioFlorida’s annual conference on Oct. 15-17 in St. Petersburg.

Olcese co-founded KynderMed to market light-emitting sleep mask technology designed to reduce the risk of preterm labor by inhibiting contractions overnight.

The mask emits blue light while a pregnant woman is sleeping. Research conducted with late-term pregnant volunteers at Tallahassee Memorial Hospital found that exposing women to bright light for an hour overnight reduced levels of melatonin, a hormone that has been shown to cause contractions that can lead to preterm labor.